On 2025-08-12, Vor Biopharma Inc. (VOR) announced earnings per share of $-43.60 for the fiscal quarter ending 2025-06-30, missing the average analyst estimate of $-11.40.
The next expected annoucement date for quarterly earnings is 2025-11-06, with an average estimated earnings per share of $-3.20 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-12 | 2025-06-30 | $-11.40 | $-43.60 |
| 2025-05-14 | 2025-03-31 | $-5.00 | $-5.20 |
| 2025-03-20 | 2024-12-31 | $-5.00 | $-8.80 |
| 2024-11-07 | 2024-09-30 | $-8.00 | $-8.00 |
| 2024-08-08 | 2024-06-30 | $-8.20 | $-8.20 |
| 2024-05-09 | 2024-03-31 | $-7.40 | $-9.00 |
| 2024-03-20 | 2023-12-31 | $-9.80 | $-7.80 |
| 2023-11-07 | 2023-09-30 | $-9.20 | $-9.80 |
| 2023-08-10 | 2023-06-30 | $-8.40 | $-9.00 |
| 2023-05-11 | 2023-03-31 | $-7.60 | $-8.60 |
| 2023-03-23 | 2022-12-31 | $-11.20 | $-10.60 |
| 2022-11-10 | 2022-09-30 | $-12.00 | $-12.60 |
| 2022-08-11 | 2022-06-30 | $-13.40 | $-11.60 |
| 2022-05-12 | 2022-03-31 | $-10.80 | $-12.20 |
| 2022-03-14 | 2021-12-31 | $-11.00 | $-9.80 |
| 2021-11-10 | 2021-09-30 | $-11.60 | $-10.00 |
| 2021-08-09 | 2021-06-30 | $-9.40 | $-10.00 |
| 2021-05-06 | 2021-03-31 | $-16.60 | $-13.40 |